$13.99
0.312.27%
At close: -
$13.99
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
RXO Analyst Ratings and Price Targets | NYSE:RXO | Benzinga
RXO Inc has a consensus price target of $22.35 based on the ratings of 23 analysts. The high is $31 issued by Wells Fargo on November 11, 2024. The low is $13 issued by Susquehanna on March 26, 2025. The 3 most-recent analyst ratings were released by Jefferies, Goldman Sachs, and Citigroup on April 11, 2025, April 10, 2025, and April 8, 2025, respectively. With an average price target of $18.67 between Jefferies, Goldman Sachs, and Citigroup, there's an implied 33.43% upside for RXO Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Jefferies
Goldman Sachs
Citigroup
Barclays
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for RXO
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/11/2025 | Buy Now | 42.96% | Jefferies | Stephanie Moore58% | $26 → $20 | Maintains | Buy | Get Alert |
| 04/10/2025 | Buy Now | 50.11% | Goldman Sachs | Jordan Alliger68% | $24 → $21 | Maintains | Neutral | Get Alert |
| 04/08/2025 | Buy Now | 7.22% | Citigroup | Ariel Rosa68% | $23 → $15 | Maintains | Neutral | Get Alert |
| 04/04/2025 | Buy Now | — | Oppenheimer | Scott Schneeberger62% | — | Downgrade | Outperform → Perform | Get Alert |
| 04/02/2025 | Buy Now | 57.26% | Barclays | Brandon Oglenski61% | $24 → $22 | Maintains | Overweight | Get Alert |
| 03/27/2025 | Buy Now | 42.96% | Wells Fargo | Christian Wetherbee71% | $22 → $20 | Maintains | Equal-Weight | Get Alert |
| 03/26/2025 | Buy Now | -7.08% | Susquehanna | Bascome Majors57% | $18 → $13 | Maintains | Negative | Get Alert |
| 03/13/2025 | Buy Now | 71.55% | Truist Securities | Lucas Servera20% | → $24 | Initiates | → Buy | Get Alert |
| 02/06/2025 | Buy Now | 71.55% | Goldman Sachs | Jordan Alliger68% | $28 → $24 | Maintains | Neutral | Get Alert |
| 02/06/2025 | Buy Now | 71.55% | Stifel | J. Bruce Chan43% | $27 → $24 | Maintains | Hold | Get Alert |
| 02/06/2025 | Buy Now | 78.7% | Morgan Stanley | Ravi Shanker57% | $27 → $25 | Maintains | Equal-Weight | Get Alert |
| 01/23/2025 | Buy Now | 92.99% | Stifel | J. Bruce Chan43% | $26 → $27 | Maintains | Hold | Get Alert |
| 01/17/2025 | Buy Now | 114.44% | Barclays | Brandon Oglenski61% | $32 → $30 | Maintains | Overweight | Get Alert |
| 01/15/2025 | Buy Now | — | Benchmark | Christopher Kuhn52% | — | Reiterates | Hold → Hold | Get Alert |
| 01/10/2025 | Buy Now | 114.44% | Jefferies | Stephanie Moore58% | $33 → $30 | Maintains | Buy | Get Alert |
| 01/07/2025 | Buy Now | 100.14% | Wells Fargo | Christian Wetherbee71% | $31 → $28 | Maintains | Equal-Weight | Get Alert |
| 11/18/2024 | Buy Now | 107.29% | Goldman Sachs | Jordan Alliger68% | → $29 | Reinstates | → Neutral | Get Alert |
| 11/12/2024 | Buy Now | -14.22% | Susquehanna | Bascome Majors57% | $16 → $12 | Maintains | Negative | Get Alert |
| 11/12/2024 | Buy Now | 135.88% | Citigroup | Ariel Rosa68% | $33 → $33 | Downgrade | Buy → Neutral | Get Alert |
| 11/11/2024 | Buy Now | 121.59% | Wells Fargo | Allison Poliniak72% | → $31 | Reinstates | Equal-Weight → Equal-Weight | Get Alert |
| 10/15/2024 | Buy Now | — | Benchmark | Christopher Kuhn70% | — | Reiterates | → Hold | Get Alert |
| 10/09/2024 | Buy Now | 135.88% | Citigroup | Ariel Rosa68% | → $33 | Initiates | → Buy | Get Alert |
| 09/26/2024 | Buy Now | 14.37% | Susquehanna | Bascome Majors57% | $20 → $16 | Maintains | Negative | Get Alert |
| 09/17/2024 | Buy Now | 121.59% | Oppenheimer | Scott Schneeberger62% | $31 → $31 | Reiterates | Outperform → Outperform | Get Alert |
| 08/15/2024 | Buy Now | 42.96% | Susquehanna | Bascome Majors57% | $14 → $20 | Maintains | Negative | Get Alert |
| 08/13/2024 | Buy Now | 121.59% | Jefferies | Stephanie Moore58% | $33 → $31 | Maintains | Buy | Get Alert |
| 08/13/2024 | Buy Now | — | Benchmark | Christopher Kuhn70% | — | Reiterates | → Hold | Get Alert |
| 08/12/2024 | Buy Now | 85.85% | Morgan Stanley | Ravi Shanker57% | $19 → $26 | Maintains | Equal-Weight | Get Alert |
| 08/08/2024 | Buy Now | 100.14% | TD Cowen | Jason Seidl54% | $23 → $28 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | 85.85% | JP Morgan | Brian Ossenbeck65% | $25 → $26 | Maintains | Underweight | Get Alert |
| 08/08/2024 | Buy Now | 121.59% | Oppenheimer | Scott Schneeberger62% | $22 → $31 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | 121.59% | UBS | Joseph Parkhill74% | $22 → $31 | Maintains | Neutral | Get Alert |
| 07/16/2024 | Buy Now | 114.44% | Barclays | Brandon Oglenski61% | $24 → $30 | Maintains | Overweight | Get Alert |
| 07/09/2024 | Buy Now | 78.7% | JP Morgan | Brian Ossenbeck65% | $16 → $25 | Maintains | Underweight | Get Alert |
| 06/12/2024 | Buy Now | — | Benchmark | Christopher Kuhn70% | — | Reiterates | → Hold | Get Alert |
| 05/15/2024 | Buy Now | — | Raymond James | Felix Boeschen72% | — | Reinstates | → Market Perform | Get Alert |
| 05/06/2024 | Buy Now | 57.26% | Stephens & Co. | Daniel Imbro65% | $22 → $22 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 04/19/2024 | Buy Now | — | Benchmark | Christopher Kuhn70% | — | Reiterates | → Hold | Get Alert |
| 03/26/2024 | Buy Now | 14.37% | Susquehanna | Bascome Majors57% | $15 → $16 | Maintains | Negative | Get Alert |
| 03/25/2024 | Buy Now | 14.37% | Susquehanna | Bascome Majors57% | $15 → $16 | Maintains | Negative | Get Alert |
| 02/13/2024 | Buy Now | 57.26% | Oppenheimer | Scott Schneeberger62% | $23 → $22 | Maintains | Outperform | Get Alert |
| 02/09/2024 | Buy Now | 7.22% | Susquehanna | Bascome Majors57% | $18 → $15 | Maintains | Negative | Get Alert |
| 02/08/2024 | Buy Now | 57.26% | B of A Securities | Ken Hoexter64% | $25 → $22 | Downgrade | Buy → Neutral | Get Alert |
| 01/10/2024 | Buy Now | 57.26% | Stifel | J. Bruce Chan43% | $20 → $22 | Maintains | Hold | Get Alert |
| 01/10/2024 | Buy Now | 64.4% | Vertical Research | Jeffrey Kauffman64% | → $23 | Downgrade | Buy → Hold | Get Alert |
| 10/16/2023 | Buy Now | 21.52% | Stifel | J. Bruce Chan43% | $19 → $17 | Maintains | Hold | Get Alert |
| 10/11/2023 | Buy Now | 14.37% | JP Morgan | Brian Ossenbeck65% | $17 → $16 | Downgrade | Neutral → Underweight | Get Alert |
| 10/03/2023 | Buy Now | -7.08% | Susquehanna | Bascome Majors57% | $14 → $13 | Maintains | Negative | Get Alert |
| 10/02/2023 | Buy Now | 28.66% | Morgan Stanley | Ravi Shanker57% | $20 → $18 | Maintains | Equal-Weight | Get Alert |
| 08/31/2023 | Buy Now | 0.07% | Susquehanna | Bascome Majors57% | $19 → $14 | Downgrade | Neutral → Negative | Get Alert |
| 08/07/2023 | Buy Now | 71.55% | Oppenheimer | Scott Schneeberger62% | → $24 | Reiterates | Outperform → Outperform | Get Alert |
| 08/03/2023 | Buy Now | 42.96% | Morgan Stanley | Ravi Shanker57% | $20 → $20 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/03/2023 | Buy Now | 35.81% | Stephens & Co. | Jack Atkins65% | $23 → $19 | Maintains | Equal-Weight | Get Alert |
| 07/12/2023 | Buy Now | 35.81% | Wolfe Research | Scott Group59% | → $19 | Downgrade | Peer Perform → Underperform | Get Alert |
| 07/06/2023 | Buy Now | 42.96% | Morgan Stanley | Ravi Shanker57% | $20 → $20 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/09/2023 | Buy Now | 42.96% | Susquehanna | Bascome Majors57% | → $20 | Initiates | → Neutral | Get Alert |
| 05/24/2023 | Buy Now | 92.99% | Barclays | Brandon Oglenski61% | → $27 | Initiates | → Overweight | Get Alert |
| 05/04/2023 | Buy Now | 50.11% | Wells Fargo | Allison Poliniak72% | $22 → $21 | Maintains | Equal-Weight | Get Alert |
| 04/04/2023 | Buy Now | — | Benchmark | Christopher Kuhn70% | — | Initiates | → Hold | Get Alert |
| 02/27/2023 | Buy Now | 57.26% | Cowen & Co. | Jason Seidl54% | → $22 | Initiates | → Market Perform | Get Alert |
| 02/09/2023 | Buy Now | 64.4% | UBS | Joseph Parkhill74% | $20 → $23 | Maintains | Neutral | Get Alert |
| 02/09/2023 | Buy Now | 57.26% | Goldman Sachs | Jordan Alliger68% | $20 → $22 | Maintains | Neutral | Get Alert |
| 02/09/2023 | Buy Now | 71.55% | Oppenheimer | Scott Schneeberger62% | $21 → $24 | Maintains | Outperform | Get Alert |
| 02/08/2023 | Buy Now | 42.96% | Stephens & Co. | Jack Atkins65% | → $20 | Maintains | Equal-Weight | Get Alert |
| 01/11/2023 | Buy Now | 21.52% | Stifel | J. Bruce Chan43% | $20 → $17 | Downgrade | Buy → Hold | Get Alert |
| 01/09/2023 | Buy Now | 35.81% | JP Morgan | Brian Ossenbeck65% | → $19 | Initiates | → Neutral | Get Alert |
| 12/20/2022 | Buy Now | 28.66% | Wells Fargo | Allison Poliniak72% | → $18 | Initiates | → Equal-Weight | Get Alert |
| 12/09/2022 | Buy Now | 42.96% | UBS | Thomas Wadewitz70% | → $20 | Initiates | → Neutral | Get Alert |
| 12/09/2022 | Buy Now | 42.96% | Morgan Stanley | Ravi Shanker57% | → $20 | Initiates | → Equal-Weight | Get Alert |
| 12/06/2022 | Buy Now | 78.7% | Jefferies | Stephanie Moore58% | → $25 | Initiates | → Buy | Get Alert |
| 12/05/2022 | Buy Now | — | Raymond James | Felix Boeschen72% | — | Initiates | → Market Perform | Get Alert |
| 11/30/2022 | Buy Now | 57.26% | B of A Securities | Ken Hoexter64% | → $22 | Initiates | → Buy | Get Alert |
| 11/22/2022 | Buy Now | 50.11% | Oppenheimer | Scott Schneeberger62% | → $21 | Initiates | → Outperform | Get Alert |
| 11/22/2022 | Buy Now | 42.96% | Goldman Sachs | Jordan Alliger68% | → $20 | Initiates | → Neutral | Get Alert |
| 11/21/2022 | Buy Now | 92.99% | Vertical Research | Jeffrey Kauffman64% | → $27 | Initiates | → Buy | Get Alert |
| 11/10/2022 | Buy Now | — | Wolfe Research | Scott Group59% | — | Initiates | → Peer Perform | Get Alert |
| 11/04/2022 | Buy Now | 42.96% | Stifel | J. Bruce Chan43% | → $20 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for RXO (RXO) stock?
The latest price target for RXO (NYSE:RXO) was reported by Jefferies on April 11, 2025. The analyst firm set a price target for $20.00 expecting RXO to rise to within 12 months (a possible 42.96% upside). 38 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for RXO (RXO)?
The latest analyst rating for RXO (NYSE:RXO) was provided by Jefferies, and RXO maintained their buy rating.
When was the last upgrade for RXO (RXO)?
There is no last upgrade for RXO
When was the last downgrade for RXO (RXO)?
The last downgrade for RXO Inc happened on April 4, 2025 when Oppenheimer changed their price target from N/A to N/A for RXO Inc.
When is the next analyst rating going to be posted or updated for RXO (RXO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of RXO, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for RXO was filed on April 11, 2025 so you should expect the next rating to be made available sometime around April 11, 2026.
Is the Analyst Rating RXO (RXO) correct?
While ratings are subjective and will change, the latest RXO (RXO) rating was a maintained with a price target of $26.00 to $20.00. The current price RXO (RXO) is trading at is $13.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.